Clinical Trial Update: Efficacy And Safety Evaluation of Glepaglutide in Treatment of SBS [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating the efficacy and safety of glepaglutide for short bowel syndrome is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Short Bowel Syndrome

Drugs mentioned

• Glepaglutide (glepaglutide)

Snippet

Sponsor: Zealand Pharma | Conditions: Short Bowel Syndrome | Phase 3 | Status: RECRUITING